Joincare Pharmaceutical Group Industry Co Ltd (600380) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Joincare Pharmaceutical Group Industry Co Ltd (600380) has a cash flow conversion efficiency ratio of 0.045x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥1.09 Billion ≈ $159.61 Million USD) by net assets (CN¥24.08 Billion ≈ $3.52 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 600380 market cap overview for the company's overall valuation and market capitalisation.
Joincare Pharmaceutical Group Industry Co Ltd - Cash Flow Conversion Efficiency Trend (1999–2025)
This chart illustrates how Joincare Pharmaceutical Group Industry Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Joincare Pharmaceutical Group Industry Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Joincare Pharmaceutical Group Industry Co Ltd ranked by their cash flow conversion efficiency. Explore earnings quality score of Joincare Pharmaceutical Group Industry C to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ducommun Incorporated
NYSE:DCO
|
0.049x |
|
Kaiser Aluminum Corporation
NASDAQ:KALU
|
0.100x |
|
TAG IMMOBILIEN ADR 1/2
F:TEG0
|
0.040x |
|
ACC Limited
NSE:ACC
|
-0.111x |
|
Jiangsu Dingsheng New Material Joint-Stock Co Ltd
SHG:603876
|
0.012x |
|
Unibel S.A
PA:UNBL
|
0.077x |
|
ANSELL (UNSP.ADRS)/4
F:PD1
|
N/A |
|
Digital China Group Co Ltd
SHE:000034
|
-0.106x |
Annual Cash Flow Conversion Efficiency for Joincare Pharmaceutical Group Industry Co Ltd (1999–2025)
The table below shows the annual cash flow conversion efficiency of Joincare Pharmaceutical Group Industry Co Ltd from 1999 to 2025. View latest Joincare Pharmaceutical Group Industry C stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥24.37 Billion ≈ $3.57 Billion |
CN¥3.89 Billion ≈ $569.50 Million |
0.160x | +2.78% |
| 2024-12-31 | CN¥23.40 Billion ≈ $3.42 Billion |
CN¥3.64 Billion ≈ $532.11 Million |
0.155x | -10.46% |
| 2023-12-31 | CN¥22.64 Billion ≈ $3.31 Billion |
CN¥3.93 Billion ≈ $574.92 Million |
0.174x | -3.93% |
| 2022-12-31 | CN¥22.02 Billion ≈ $3.22 Billion |
CN¥3.98 Billion ≈ $582.06 Million |
0.181x | +42.22% |
| 2021-12-31 | CN¥20.18 Billion ≈ $2.95 Billion |
CN¥2.56 Billion ≈ $375.06 Million |
0.127x | -19.23% |
| 2020-12-31 | CN¥19.24 Billion ≈ $2.81 Billion |
CN¥3.02 Billion ≈ $442.65 Million |
0.157x | +18.21% |
| 2019-12-31 | CN¥17.38 Billion ≈ $2.54 Billion |
CN¥2.31 Billion ≈ $338.38 Million |
0.133x | +18.75% |
| 2018-12-31 | CN¥16.30 Billion ≈ $2.38 Billion |
CN¥1.83 Billion ≈ $267.13 Million |
0.112x | -18.44% |
| 2017-12-31 | CN¥13.62 Billion ≈ $1.99 Billion |
CN¥1.87 Billion ≈ $273.69 Million |
0.137x | -22.04% |
| 2016-12-31 | CN¥9.33 Billion ≈ $1.37 Billion |
CN¥1.64 Billion ≈ $240.65 Million |
0.176x | +1.80% |
| 2015-12-31 | CN¥7.31 Billion ≈ $1.07 Billion |
CN¥1.26 Billion ≈ $185.05 Million |
0.173x | +15.58% |
| 2014-12-31 | CN¥6.54 Billion ≈ $957.23 Million |
CN¥979.46 Million ≈ $143.33 Million |
0.150x | +41.93% |
| 2013-12-31 | CN¥6.02 Billion ≈ $881.55 Million |
CN¥635.52 Million ≈ $93.00 Million |
0.105x | -19.69% |
| 2012-12-31 | CN¥5.59 Billion ≈ $818.10 Million |
CN¥734.36 Million ≈ $107.46 Million |
0.131x | +10.27% |
| 2011-12-31 | CN¥5.46 Billion ≈ $798.94 Million |
CN¥650.36 Million ≈ $95.17 Million |
0.119x | -42.70% |
| 2010-12-31 | CN¥5.32 Billion ≈ $778.05 Million |
CN¥1.11 Billion ≈ $161.74 Million |
0.208x | +51.08% |
| 2009-12-31 | CN¥4.40 Billion ≈ $644.12 Million |
CN¥605.66 Million ≈ $88.63 Million |
0.138x | +16.78% |
| 2008-12-31 | CN¥3.86 Billion ≈ $565.10 Million |
CN¥455.01 Million ≈ $66.58 Million |
0.118x | +11.73% |
| 2007-12-31 | CN¥4.07 Billion ≈ $595.64 Million |
CN¥429.26 Million ≈ $62.81 Million |
0.105x | +11.54% |
| 2006-12-31 | CN¥2.88 Billion ≈ $421.74 Million |
CN¥272.50 Million ≈ $39.88 Million |
0.095x | -21.15% |
| 2005-12-31 | CN¥3.03 Billion ≈ $443.13 Million |
CN¥363.13 Million ≈ $53.14 Million |
0.120x | +47.47% |
| 2004-12-31 | CN¥2.97 Billion ≈ $434.97 Million |
CN¥241.71 Million ≈ $35.37 Million |
0.081x | +43.15% |
| 2003-12-31 | CN¥3.03 Billion ≈ $443.74 Million |
CN¥172.25 Million ≈ $25.21 Million |
0.057x | -51.61% |
| 2002-12-31 | CN¥2.01 Billion ≈ $294.39 Million |
CN¥236.13 Million ≈ $34.55 Million |
0.117x | +3.91% |
| 2001-12-31 | CN¥1.98 Billion ≈ $289.91 Million |
CN¥223.79 Million ≈ $32.75 Million |
0.113x | -83.03% |
| 2000-12-31 | CN¥257.75 Million ≈ $37.72 Million |
CN¥171.61 Million ≈ $25.11 Million |
0.666x | +15.13% |
| 1999-12-31 | CN¥189.89 Million ≈ $27.79 Million |
CN¥109.82 Million ≈ $16.07 Million |
0.578x | -- |
About Joincare Pharmaceutical Group Industry Co Ltd
Joincare Pharmaceutical Group Industry Co.,Ltd. engages in the research, development, production, and sale of pharmaceuticals and health care products in China and internationally. The company offers chemical pharmaceuticals for respiratory, gastroenterology, assisted reproduction, psychiatry, and anti-infection; chemical APIs and intermediates for drugs for humans and veterinary drugs; and tradi… Read more